Written by:Fact check:

Overview

What Is Dyskeratosis Congenita?

Dyskeratosis congenita is a rare inherited disorder in which the body has trouble maintaining telomeres, protective structures at the ends of chromosomes. This telomere problem can cause bone marrow failure and characteristic changes in the skin, nails, and mouth. It may also affect the lungs, liver, bones, and other organs. Severity and age of onset vary widely, even among members of the same family.

Symptoms

Symptoms of Dyskeratosis Congenita

Symptoms of dyskeratosis congenita can appear in childhood, adolescence, or adulthood, and not everyone has the same combination of findings. Some signs may be subtle at first, but they can progress as bone marrow and other organs become affected.

  • Abnormal nail development or nail dystrophy
  • Lacy or reticulated skin pigmentation
  • White patches in the mouth (oral leukoplakia)
  • Easy bruising
  • Unusual or prolonged bleeding
  • Frequent infections
  • Persistent fatigue
  • Shortness of breath
  • Difficulty swallowing
  • Developmental differences
  • Skeletal differences, such as abnormal bone development

Causes

Causes of Dyskeratosis Congenita

Dyskeratosis congenita results from pathogenic variants in genes involved in telomere structure or maintenance. Without normally functioning telomeres, cells may age or stop dividing too early, especially in tissues that must renew themselves continuously, such as bone marrow, skin, and the lining of the mouth.

How Dyskeratosis Congenita Is Inherited

The inheritance pattern depends on the gene involved and may be X-linked, autosomal dominant, or autosomal recessive. In some people, the variant occurs newly rather than being inherited from a parent. Genetic counseling can help relatives understand testing, inheritance, and possible reproductive implications.

Risk Factors

Risk Factors for Dyskeratosis Congenita

  • Having a parent or close relative with dyskeratosis congenita or unexplained bone marrow failure increases the likelihood of an inherited telomere disorder.
  • Having a known pathogenic variant in a telomere-related gene is a major genetic risk factor.
  • Inheriting an X-linked, autosomal dominant, or autosomal recessive variant can increase the risk, depending on the gene involved.
  • A family history of early cancers or unexplained pulmonary or liver disease may suggest an inherited telomere disorder.

Complications

Complications of Dyskeratosis Congenita

  • Bone marrow failure can lead to low levels of red blood cells, white blood cells, and platelets.
  • Severe or recurrent infections may occur when white blood cell counts are low.
  • Bleeding can develop because of a low platelet count or impaired blood clotting.
  • Acute myeloid leukemia and other cancers occur more often in some people with telomere disorders.
  • Pulmonary fibrosis or respiratory failure can impair breathing.
  • Liver disease may develop as part of the multisystem disorder.
  • Osteoporosis can weaken bones and increase fracture risk.
  • Dental problems may result from oral changes, poor enamel, or treatment-related effects.
  • Esophageal narrowing can cause difficulty swallowing.
  • Developmental or neurologic complications may affect movement, learning, or nerve function.

Complication risk varies widely among people with dyskeratosis congenita. Regular surveillance is important because blood counts, organ function, and cancer risk may change over time.

Diagnosis

Diagnosis of Dyskeratosis Congenita

Clinicians consider the characteristic mucocutaneous findings, unexplained low blood counts, family history, and signs of organ involvement. Evaluation often involves hematology and medical genetics, with dermatology, pulmonology, hepatology, or other specialists involved when needed.

  • A complete blood count checks for anemia, low white blood cell counts, and low platelets.
  • A bone marrow examination may be performed when blood counts or other findings suggest marrow failure.
  • Telomere length testing assesses whether telomeres are unusually short for the person’s age.
  • Genetic testing looks for pathogenic variants associated with telomere biology disorders.
  • Pulmonary and liver assessments check for organ involvement.
  • Cancer surveillance examinations monitor for malignancies associated with telomere dysfunction.
  • Testing of relatives may be appropriate when a familial variant or inherited pattern is identified.

Understanding the diagnosis

Testing may require a specialist team

No single test is sufficient in every person. Telomere length results require specialist interpretation, and a negative initial genetic panel does not always exclude a telomere biology disorder.

Treatment & Management

Treatment and Management

Management is individualized according to blood counts, age, organ involvement, telomere length, overall health, and transplant risks. Care is coordinated by a multidisciplinary team that may include hematology, genetics, dermatology, pulmonology, gastroenterology, dentistry, and other specialists.

  • Regular monitoring and supportive transfusions may help manage blood-count problems.
  • Growth factors or other specialist-directed medicines may be used when appropriate.
  • Hematopoietic stem cell transplantation may be considered for serious bone marrow failure.
  • Infections and bleeding are treated promptly with appropriate medical care.
  • Pulmonary or liver disease is managed with organ-specific treatment and monitoring.
  • Oral and dental care helps prevent and treat mouth and tooth complications.
  • Cancer surveillance supports early detection of cancers associated with telomere dysfunction.

Specialist treatment planning

Care must be tailored to telomere biology

Transplantation can treat bone marrow failure but may not prevent non-blood complications. Conditioning regimens and other treatments may need modification because people with telomere disorders can be unusually sensitive to treatment-related toxicity.

Outlook and Prognosis

Outlook and Prognosis

The outlook for dyskeratosis congenita varies substantially by the gene involved, telomere length, age of onset, degree of bone marrow failure, organ involvement, cancer risk, and response to treatment.

Dyskeratosis congenita is a lifelong condition that generally requires ongoing hematology, genetics, and organ-specific monitoring. Because its course differs greatly from person to person, a single life-expectancy estimate cannot describe every affected individual.

When Should You See a Doctor

When Should You See a Doctor?

  • Arrange a medical evaluation for characteristic nail changes or lacy skin pigmentation.
  • Persistent white patches in the mouth should be assessed by a clinician or dental professional.
  • Unexplained low blood counts warrant evaluation for bone marrow or telomere disorders.
  • Easy bruising or unusual bleeding should be medically assessed.
  • Frequent infections or unexplained fatigue may indicate abnormal blood counts.
  • A close relative with dyskeratosis congenita should prompt discussion with a clinician or genetic counselor.

Seek urgent medical care

Some complications need immediate attention

Seek urgent care for fever during known or suspected low blood counts, uncontrolled bleeding, severe shortness of breath, chest pain, confusion, or rapidly worsening weakness.

People with a suspected inherited telomere disorder should seek assessment from a clinician experienced in hematology or medical genetics rather than relying on symptoms alone.

Branches

2 topics